| Literature DB >> 25911300 |
Sheo B Singh1, David E Kaelin2, Jin Wu2, Lynn Miesel2, Christopher M Tan2, Peter T Meinke2, David B Olsen3, Armando Lagrutta3, Changqing Wei4, Xuanjia Peng4, Xiu Wang4, Hideyuki Fukuda5, Ryuta Kishii5, Masaya Takei5, Takeshi Shibata5, Kohei Ohata5, Hisashi Takano5, Haruaki Kurasaki5, Tomoko Takeuchi5, Akinori Nishimura5, Yasumichi Fukuda6.
Abstract
Bacterial resistance is rapidly growing, necessitating the need to discover new agents. Novel bacterial topoisomerase inhibitors (NBTIs) are new class of broad-spectrum antibacterial agents targeting bacterial DNA gyrase and topoisomerase IV. This class of inhibitors binds to an alternative binding site relative to fluoroquinolones and shows no cross-resistance to quinolones. NBTIs consist of three structural motifs. A structure activity relationship of the left hand motif 1,5-naphthyridine of oxabicyclooctane-linked NBTIs is described. Fifty five compounds were evaluated against a panel of key Gram-positive and Gram-negative strains of bacteria, as well as for hERG activity and five compounds were tested for in vivo efficacy in murine model of Staphylococcus aureus infection. These studies suggest that only a narrow range (activating and deactivating) of substitutions at C-2 and C-7 are tolerated for optimal antibacterial activity and spectrum. An alkoxy (methoxy) and CN at C-2, and a halogen and hydroxyl at C-7, appeared to be preferred in this series. Substitutions on the other three carbons generally have detrimental effect on the activity. No clear hERG activity SAR emerged from these substitutions.Entities:
Keywords: Antibacterial; Bacterial topoisomerase inhibitors; Broad-spectrum; Gyrase inhibitors; ParC inhibitors
Mesh:
Substances:
Year: 2015 PMID: 25911300 DOI: 10.1016/j.bmcl.2015.04.002
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823